Abstract:To compare the effects of inhalation of salmeterol/fluticasone with fluticasone propionate monotherapy on small airway functions of patients with uncontrolled asthma.Methods In this randomized, stratified,double-blind,and parallel-group study,34 symptomatic asthmatics patients were randomly divided into 2 groups and received either salmeterol/fluticasone(n=18)or fluticasone(n=16)twice daily respectively,via a single Diskus inhaler for 52 weeks.The initial dosage of inhaled corticosteroid at the randomization for each patient was determined according to their individual treatment before the study.The dosage of fluticasone was stepped-up until totally controlled asthma was achieved(or maximum 500 μg fluticasone twice a day).Forced expiratory flow at 50% of vital capacity(FEF50),forced expiratory flow at 75% of vital capacity(FEF75),maximum midexpiratory flow rate(MMEF)and forced expiratory volume during the first second(FEV_1),and peak expiratory flow(PEF)at the baseline and the end of 4,12, 24,36,48,and 52 weeks of treatment were evaluated,as well as the number of patients who achieved 12% improvement in these parameters.Results FEF50,FEF75,and MMEF(2.09±0.95,0.70±0.47 and 1.67±0.87 L/s,respectively)were significantly increased at the end of week 4 compared with baseline (1.70±0.76,0.58±0.34 and 1.37±0.70 L/s,respectively)and remained in the subsequent follow-ups with combination inhaled salmeterol/fluticasone,whereas no significant increases in FEFS0,FEF75,and MMEF were observed until the end of week 12 with inhaled fluticasone.There were 77.8%,66.7%,and 72.2% of patients respectively with inhalation of salmeterol/fluticasone achieved a 12% improvement in FEF50,FEF75,and MMEF at the end of week 4,compared with 43.8%,20.0%,and 37.5% with fluticasone alone(all P0.05).100% of the patients with salmeterol/fluticasone achieved a 12% improvement in FEF50 at the end of week 52,whereas only 75% with fluticasone(P0.05).At the end of week 52,72.2% and 37.5% of the patients achieved a 12% improvement in FEV_1,with salmeterol/ fluticasone group and fluticasone alone respectively and the difference was statistically significant too. Contusion For improving small airway functions in patients with uncontrolled asthma,almeterol/ fluticasone is more effective and the improvement achieved more rapidly compared with fluticasone alone.

A Randomized Comparative Trial of Clarithromycin Combined Regimens Containing Salmeterol/Fluticasone for Treatment of Bronchial Asthma

Clinical study of salmeterol/fluticasone on asthma

Efficacy of Long-term Inhaled Salmeterol/Fluticasone Combined with Low-dose Oral Erythromycin in Patients with Bronchiectasis

Effect of Inhaled Salmeterol-Fluticasone Combined with Low-Dose Erythromycin on Ciliary Ultrastructure and Mucociliary Clearance of Airway in Patients with Bronchiectasis

Combined Inhaled Corticosteroid and Long-Acting Β2-Adrenergic Agonist Therapy for Noncystic Fibrosis Bronchiectasis with Airflow Limitation

The Efficacy and Safety of Azithromycin in Asthma: A Systematic Review

Salmeterol/fluticasone Combined with N-acetylcysteine in Treatment of Airway Inflammation of Stable Chronic Obstructive Pulmonary Disease

Influence Analysis of Salmeterol Fluticasone and Budesonide to Lung Function of Patients with Bronchial Asthma

Clinical efficacy and value of clarithromycin with tiotropium for curing COPD

Effect of of Jinshuibao capsules combined with Salmeterol Fluticasone Propionate Powder inhalation on clinical efficacy, lung function and cellular immune factors in patients with bronchial asthma

Clinical Evaluation of Different Doses of Salmeterol and Fluticasone in Adjuvant Treatment of Bronchial Asthma

Clinical study on Pingfeng Shengmai Capsules combined with Salmeterol Xinafoate and Fluticasone Propionate Aerosol in treatment of bronchial asthma

Clinical evaluation on the empirical treatment of community acquired pneumonia

EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma

Comparison of the Effects of Salmeterol/fluticasone Versus Fluticasone over 1-Year on Small Airway Functions in Asthmatics

Clarithromycin Combined Singulair Treatment of Mycoplasma Infection-induced Chronic Cough

Efficacy of Fluticasone and Salmeterol Dry Powder in Treating Patients with Bronchial Asthma and Its Effect on Inflammatory Factors and Pulmonary Function

Clinical curative effect of salmeterol fluticasone in asthma therapy and its influence on lung function and serum CRP

Effect of Salmeterol/fluticasone on Serum Levels of Interleukin-21 and Total IgE in Asthmatic Patients

[Evaluation of the Clinical Efficacy and the Safety of Salmeterol/fluticasone Propionate Accuhaler Compared to Budesonide Turbuhalar in the Control of Adult Asthma].

The Clinical Efficacy of Combining Ambroxol Hydrochloride with Antibiotics for the Treatment of Chronic Bronchitis